期刊文献+

基质金属蛋白酶-9在体外循环肺损伤中作用的初步研究 被引量:21

The effect of matrix metalloproteinase-9 in acute lung injury following cardiopulmonary bypass
在线阅读 下载PDF
导出
摘要 目的 :探讨基质金属蛋白酶 9(MMP 9)在围体外循环术 (CPB)中的变化及其与肺损伤的相关性。 方法 :临床选择 2 0例接受CPB术的患者 ,分别测定CPB开始 (术中进行肝素化之前 )、开始后 5min、结束时 (鱼精蛋白中和之前 )、结束后 1h和 6h血浆MMP 9浓度 ,同时测定CPB结束后各时间点的肺泡 动脉氧分压差 (A aDO2 )、呼吸指数 (RI) ,记录主动脉阻断时间、转流时间及拔管时间。 结果 :①在CPB结束时及结束后 1h血浆MMP 9的浓度与基础值及CPB开始后 5min相比有显著差异 (P <0 .0 1) ,其中在CPB结束时血浆MMP 9的浓度达到最高峰值 ,之后呈下降趋势 ,6h后接近基础值 ;②血浆MMP 9浓度与主动脉阻断时间有较明显的相关性 ,与转流时间相关性不甚明显 ;③由于术后肺损伤实际发生率较低 ,尤其是早期肺损伤不易测定 ,因此在血浆MMP 9浓度的变化与术后肺功能损伤之间未见有明显相关性。 结论 :CPB可以引起血浆MMP 9浓度的明显增高 。 Objectives: To study the correlation between plasma matrix metalloproteinase 9(MMP 9) concentration and acute lung injury following cardiopulmonary bypass(CPB). Methods: Human plasma was obtained after informed consent from twenty patients undergoing CPB. Plasma was collected at the beginning of CPB, 5 minutes after the initiation of CPB, at the termination of CPB, 1 hour after the termination of CPB and 6 hours after the termination of CPB. All samples were analyzed by standard enzyme linked immunosorbent assay (ELISA). A aDO 2 and respiratory index (RI) was measured at the termination, 1 hour and 6 hours after termination of CPB. The cross clamp times, CPB times and the time to extubation was recorded. Data were expressed as means ±SE and assessed by analysis of variance (ANOVA).The regression analysis was utilized to define the correlations of variables measured( A aDO 2 ,RI, cross clamp times, CPB times and the time to extubation ) at the end of CPB. Results: Plasma MMP 9 concentration was significantly increased at the end of CPB (430.6±50)μg/L( P < 0.01 ) as compared with both the start of CPB(42.6±3.2)μg/L and 5 minutes after the initiation of CPB (97.5±22.8)μg/L. 6 hours after the termination of CPB plasma MMP 9 concentration was close to the concentration of basement level. The correlation between plasma MMP 9 concentration at the end of CPB and cross clamp times was significant. The correlation between lung injury and increased plasma MMP 9 concentration was not significant as we were unable to demonstrate any pulmonary dysfunction in these 20 patients. Conclusions: Patients undergoing CPB showed a significant increase in plasma MMP 9 levels and the effect of cross clamp time was more remarkable.
出处 《医学研究生学报》 CAS 2003年第5期361-364,共4页 Journal of Medical Postgraduates
关键词 体外循环术 基质金属蛋白酶-9 肺损伤 Cardiopulmonary bypass Matrix metalloproteinase 9 Lung injury
  • 相关文献

参考文献13

  • 1仇万山,景华.体外循环与炎性肺损伤[J].医学研究生学报,2001,14(2):164-168. 被引量:6
  • 2仇万山,景华.体外循环对肺的影响[J].医学研究生学报,2001,14(3):260-261. 被引量:4
  • 3Carden D, Xiao F, Moak C et al. Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins[J]. Am J Physiol, 1998,275:H385- H392.
  • 4Alexander JS, Elrod JW. Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation[J]. J Anat, 2002,200:561-574.
  • 5Steinberg J, Fink G, Picone A et al. Evidence of increased matrix metalloproteinase-9 concentration in patients following cardiopulmonary bypass[J]. J Extra Corpor Technol, 2001,33:218-222.
  • 6Joffs C, Gunasinghe HR, Multani MM et al. Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases[J]. Ann Thorac Surg,2001,71:1518-1523.
  • 7Yamazaki T, Ooshima H, Usui A et al. Protective effects of ONO5046 Na, a specific neutrohpil elastase inhibitor on postperfusion lung injury[J]. Ann Thorac Surg,1999,68:2141-2146.
  • 8Asimakopoulos G, Smith P, ratnaturga S et al. Lung injury and ARDS after cardiopulmonary bypass[J]. Ann Thorac Surg,1999,68:1107-1115.
  • 9Milot J, Perron J, Lacasse Y et al. Incidence and predictors of ARDS after cardiac surgery[J]. Chest, 2001,119:884-888.
  • 10Teletha SG, Nicolas MB, Thomas PS. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury[J]. J Immunol,1999, 162: 3653-3662.

二级参考文献35

  • 1宋勇,黎介寿.血管内皮细胞在全身炎症反应综合征中的作用[J].医学研究生学报,1999,12(2):48-50. 被引量:2
  • 2Albelda SM,Smith CW,Ward PA.Adhesion molecules and inflammatory injury[J].FASEB J,1994,8:504-512.
  • 3Friedman M,Wang SY,Franklin A,et al.Pulmonary injury after total partial cardiopulmonary bypass with thromboxane synthesis inhibition[J].Ann Thorac Surg,1995,59:598-603.
  • 4Kubes P,Ibbotson G,Russell J,et al.Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence[J].Am J Physiol,1990,259:G300-305.
  • 5Sawa Y,Schaper J,Roth M,et al.Platelet-activating factor plays an important role in reperfusion injury in myocardium:efficacy of platelet-activating factor receptor antagonist(CV-3988) as compared with leukocyte-depleted reperfusion[J].Ann Thorac Cardiovasc Surg,1994,108:953-959.
  • 6Zehr KJ,Poston RS,Lee PC,et al.Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass[J].Ann Thorac Surg,1995,59:328-35.
  • 7Jansen NJG,van Oeveren W,Gu YJ,et al.Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass[J].Ann Thorac Surg,1992,54:744-748.
  • 8Stenberg JB,Kapelanski DP,Olson JD,et al.Cytokine and complement levels in patients undergoing cardiopulmonary bypass[J].J Thorac Cardiovasc Surg,1993,106:1008-1016.
  • 9Wakefield TW,Kirsh MM,Till GO,et al.Absence of complement-mediated events after protamine reversal of heparin anticoagulation[J].J Surg Res,1991,51:72-76.
  • 10Seghaye MC,Duchateau J,Grabitz RG,et al.Complement activation during cardiopulmonary bypass in infants and children:relation to postoperative multiple system organ failure[J].J Thorac Cardiovasc Surg,1993,106:978-987.

共引文献8

同被引文献188

引证文献21

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部